VBI 9-Rated AmerisourceBergen Now On Our Radar

June 4, 2019

Let’s take a look at VBI 9-rated stock AmerisourceBergen, a pharmaceutical sourcing and distribution company that yields 2% as of this writing. We like AmerisourceBergen’s dividend growth story, strong free cash flow generation, guidance raise, and relatively low net debt load. We’ll also cover AmerisourceBergen’s downside risks as well as its upside potential. Shares appear undervalued as things stand today, with ABC trading below the low end of our fair value estimate range. By Callum Turcan Pharmaceutical sourcing and distribution company AmerisourceBergen (ABC) just popped up on our radar; its fundamentals are rock-solid and its technical readings indicate Wall Street is starting to take notice. The company just registered a 9 on the Valuentum Buying Index. This American healthcare company has consistently generated

Excerpt: Big Six Banks as a Yield Play?

June 4, 2019

An article excerpt from our monthly High Yield Dividend Newsletter. Order the High Yield Dividend Newsletter here. To continue reading… become a member of the High Yield Dividend Newsletter today! —– Banks – Regional and Asset Management: AB, AINV, AMP, ARCC, BCH, BEN, BGCP, BKU, BLK, BMO, BNS, CM, FSIC, ISBC, KKR, LAZ, LM, MAIN, MTB, NABZY, NYB, OCN, PBCT, PFG, PSEC, RY, SBNY, SBSI, STT, TD, VLY, WBK  Banks & Money Centers: AXP, BAC, BBT, BK, C, DFS, FITB, GS, HBC, JPM, KEY, MS, NTRS, PNC, RF, STI, TCF, USB, WFC Related: XLF, KBE, KRE —– Valuentum members have access to our 16-page stock reports, Valuentum Buying Index ratings, Dividend Cushion ratios, fair value estimates and ranges, dividend reports and more.

Our Reports on Stocks in the Health Care Services Industry

June 4, 2019



We have dropped coverage of the Healthcare Services industry: DVA, EHC, HCA, UHS, UNH.

US Government Launches Anti-Trust War Against Alphabet, Apple, and Facebook

June 3, 2019

Image shown: Technology shares took a beating during the trading session June 3. The DOJ and FTC are coming after Alphabet, Apple and Facebook, and we can’t help but feel the moves are in some ways politically motivated. Even if regulators decide to break up these companies, it doesn’t mean they will “confiscate” their businesses. Worst case scenario, perhaps pieces of their businesses would be auctioned off at arguably above-market prices, which could be a net positive. By Brian Nelson, CFA Nobody seemingly wants big “new” tech to win, and while such a dynamic may counterintuitive turn them into great long-term investments as a result, the stock-price behavior by some of the tech heavyweights, including Alphabet (GOOG, GOOGL) and Facebook

Now a Trade War on Multiple Fronts!

June 3, 2019

This article appeared as the introduction to the June edition of the Dividend Growth Newsletter. By Callum Turcan and Brian Nelson, CFA On May 5, President Trump announced via Twitter (TWTR) that he planned to raise American tariffs on $200 billion of Chinese imports from 10% to 25%, stepping up pressure on Beijing in what we initially saw as a bid to get a trade deal over the finish line. By May 10, the new tariff rates had gone into effect and it became clear that neither side was any closer to reaching an agreement, unfortunately.  Just a few weeks ago, state-sanctioned rumors were coming out of Beijing (particularly, the editor-in-chief of the influential Global Times) that China was considering

Mall Retail Armageddon?

May 31, 2019

We think investors should be extremely cautious if they are interested in any mall retailers. Mall REITs are starting to feel some of the pain, too. By Brian Nelson, CFA Our latest channel checks at the malls foreshadowed what eventually turned into a terrible showing during the first quarter for the department stores such as J.C. Penney, Kohl’s and Nordstrom, but the apparel names and other niche shops are feeling the pain, too. It is becoming eerie when visiting the malls these days. In some of the locations we’re visiting, hardly anyone is there! Generation Z may not pick up the slack from the millennial generation, and it is showing up in the numbers big time. Here’s a run down

Dividend Increases/Decreases for the Week Ending May 31

May 31, 2019

Below we provide a list of firms that raised their dividends during the week ending May 31. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Bank of Montreal (BMO): now CAD 1.03 per share quarterly dividend, was CAD 1.00. Cleveland-Cliffs (CLF): now $0.06 per share quarterly dividend, was $0.05. Donaldson (DCI): now $0.21 per share quarterly dividend, was $0.19. Exchange Bank (EXSR): now $1.10 per share quarterly dividend, was $1.05. First Trust Enhanced Short Maturity ETF (FTSM): now $0.128 per share monthly dividend, was $0.126. Frontera Energy (FECCF): now CAD 0.205

From Nano Cap to Big Cap in Biotech

May 28, 2019

We cover some very interesting technologies in this piece, from a nano-cap company with a call option on survival, a stroke therapy firm that may improve the lives of millions, to a big-cap genomic sequencing leader that has exposure to the development of a liquid biopsy test for cancer. By Brian Nelson, CFA NeuroMetrix May Not Survive NeuroMetrix (NURO) is a nano-cap entity, a rarity when it comes to our commenting on ideas, and it comes with some unusual risks even beyond those inherent to the healthcare/biotech space. The company has incurred accumulated losses of $191 million since inception, and while it held $6.8 million in cash at the end of 2018, it may need to raise additional capital to support

Our Reports on Stocks in the Healthcare Products Distributors Industry

May 28, 2019

Images Source: Express Scripts Structure of the Healthcare Products/Distributors Industry The healthcare distributors industry is made up of wholesale medical equipment products distributors, serving the dental, medical and animal health markets, and wholesale drug providers, which distribute pharmaceuticals, medical products/services, and other healthcare technologies. Both sub-spaces are highly competitive and continue to experience growth as a result of the aging population, increased healthcare awareness, and the proliferation of medical technology and testing. Participants face pricing pressure from both customers and suppliers as a result of competition. We’re neutral on the group. We have dropped coverage of the Healthcare Products/Distributors Industry.

Investors Are Paying a Hefty Premium for NextEra Energy’s Great Dividend Growth Story

May 24, 2019

Image Source: NextEra Energy Inc – IR Presentation By Callum Turcan NextEra Energy (NEE) is one of the largest electric utility companies in North America. Management’s long-term strategy involves building out renewable energy power generation facilities all across America and Canada, namely wind farms and solar plants, while also making the necessarily investments in baseload generating facilities like nuclear power plants, natural gas-fired power plants and gas pipeline networks. Battery storage is increasingly becoming a key focus as well, as that’s what should enable renewable energy facilities to shift from intermittent to baseload power generators over time. We like NextEra’s strong growth trajectory and commitment to dividend growth, but like all utilities, a key part of its business model relies

Previous Next

About Our Name

But how, you will ask, does one decide what [stocks are] "attractive"? Most analysts feel they must choose between two approaches customarily thought to be in opposition: "value" and "growth,"...We view that as fuzzy thinking...Growth is always a component of value [and] the very term "value investing" is redundant.

                         -- Warren Buffett, Berkshire Hathaway annual report, 1992

At Valuentum, we take Buffett's thoughts one step further. We think the best opportunities arise from an understanding of a variety of investing disciplines in order to identify the most attractive stocks at any given time. Valuentum therefore analyzes each stock across a wide spectrum of philosophies, from deep value through momentum investing. And a combination of the two approaches found on each side of the spectrum (value/momentum) in a name couldn't be more representative of what our analysts do here; hence, we're called Valuentum.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Valuentum Exclusive publication, ESG Newsletter, and any reports, data and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, data or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor, and does not offer brokerage or investment banking services. The sources of the data used on this website and reports are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum, its employees, and independent contractors may have long, short or derivative positions in the securities mentioned on this website. The High Yield Dividend Newsletter portfolio, ESG Newsletter portfolio, Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio are not real money portfolios. Performance, including that in the Valuentum Exclusive publication and additional options commentary feature, is hypothetical and does not represent actual trading. Actual results may differ from simulated information, results, or performance being presented. For more information about Valuentum and the products and services it offers, please contact us at info@valuentum.com.